Schizophrenia and the gut-brain axis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 56, Issue , 2015, Pages 155-160

  Nemani, Katlyn ^a   Hosseini Ghomi, Reza ^b   McCormick, Beth ^c   Fan, Xiaoduo ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Gluten; Gut; Inflammation; Microbiota; Probiotics; Schizophrenia

Indexed keywords

FOOD ANTIGEN; MINOCYCLINE; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

CENTRAL NERVOUS SYSTEM; DIGESTIVE SYSTEM; DYSLIPIDEMIA; FECES MICROFLORA; GLUTEN FREE DIET; GUT BRAIN AXIS; HUMAN; IMMUNOREGULATION; INSULIN RESISTANCE; INTESTINE FLORA; LACTOBACILLUS GASSERI; MENTAL DISEASE; METABOLIC SYNDROME X; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; BRAIN; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTI-INFECTIVE AGENTS; BRAIN; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; SCHIZOPHRENIA;

EID: 84908072160     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.08.018     Document Type: Review

References (103)

1. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011, 11:22. 10.1186/1471-230X-11-22.
2. Arseneault-Bréard J., Rondeau I., Gilbert K., Girard S.-A., Tompkins T.A., Godbout R., et al. Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br J Nutr 2012, 107(12):1793-1799. 10.1017/S0007114511005137.
3. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008, 8(6):411-420. 10.1038/nri2316.
4. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101(44):15718-15723. 10.1073/pnas.0407076101.
5. Bäckhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007, 104(3):979-984. 10.1073/pnas.0605374104.
6. Benros M.E., Mortensen P.B., Eaton W.W. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci 2012, 1262:56-66. 10.1111/j.1749-6632.2012.06638.x.
7. Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479(7374):538-541. 10.1038/nature10554.
8. Bereswill S., Muñoz M., Fischer A., Plickert R., Haag L.-M., Otto B., et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 2010, 5(12):e15099. 10.1371/journal.pone.0015099.
9. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011, 108(38):16050-16055. 10.1073/pnas.1102999108.
10. Buscaino V. Patologia extraneurale della schizofrenia. Fegato, tubo digerente, sistema reticolo-endoteliale. Acta Neurol 1953, VIII:1-60.
11. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772. 10.2337/db06-1491.
12. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481. 10.2337/db07-1403.
13. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., Mc Evoy J.P., et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull 2011, 37(1):94-100. 10.1093/schbul/sbp055.
14. Catassi C., Bai J.C., Bonaz B., Bouma G., Calabrò A., Carroccio A., et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013, 5(10):3839-3853. 10.3390/nu5103839.
15. Coyle J.T. NMDA receptor and schizophrenia: a brief history. Schizophr Bull 2012, 38(5):920-926. 10.1093/schbul/sbs076.
16. Craven M., Egan C.E., Dowd S.E., McDonough S.P., Dogan B., Denkers E.Y., et al. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS ONE 2012, 7(7):e41594. 10.1371/journal.pone.0041594.
17. Creely S.J., McTernan P.G., Kusminski C.M., Fisher ff M., Da Silva N.F., Khanolkar M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292(3):E740-E747. 10.1152/ajpendo.00302.2006.
18. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012, 13(10):701-712. 10.1038/nrn3346.
19. Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23(3):187-192. 10.1111/j.1365-2982.2010.01664.x.
20. Davey K.J., O'Mahony S.M., Schellekens H., O'Sullivan O., Bienenstock J., Cotter P.D., et al. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 2012, 221(1):155-169. 10.1007/s00213-011-2555-2.
21. Davey K.J., Cotter P.D., O'Sullivan O., Crispie F., Dinan T.G., Cryan J.F., et al. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 2013, 3:e309. 10.1038/tp.2013.83.
22. De Santis A., Addolorato G., Romito A., Caputo S., Giordano A., Gambassi G., et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med 1997, 242(5):421-423.
23. Diaz Heijtz R., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011, 108(7):3047-3052. 10.1073/pnas.1010529108.
24. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 2010, 68(1):100-104. 10.1016/j.biopsych.2010.03.021.
25. Ding M., Song X., Zhao J., Gao J., Li X., Yang G., et al. Activation of Th17 cells in drug naïve, first episode schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 2014, 51:78-82. 10.1016/j.pnpbp.2014.01.001.
26. Dohan F.C. Wheat "consumption" and hospital admissions for schizophrenia during World War II. A preliminary report. Am J Clin Nutr 1966, 18(1):7-10.
27. Dohan F.C., Grasberger J.C. Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am J Psychiatry 1973, 130(6):685-688.
28. Dohan F.C., Harper E.H., Clark M.H., Rodrigue R.B., Zigas V. Is schizophrenia rare if grain is rare?. Biol Psychiatry 1984, 19(3):385-399.
29. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107(26):11971-11975. 10.1073/pnas.1002601107.
30. Douglas-Escobar M., Elliott E., Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013, 167(4):374-379. 10.1001/jamapediatrics.2013.497.
31. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.-Y., Agerbo E., et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006, 163(3):521-528. 10.1176/appi.ajp.163.3.521.
32. Erridge C., Duncan S.H., Bereswill S., Heimesaat M.M. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS ONE 2010, 5(2):e9125. 10.1371/journal.pone.0009125.
33. Fan X., Goff D.C., Henderson D.C. Inflammation and schizophrenia. Expert Rev Neurother 2007, 7(7):789-796. 10.1586/14737175.7.7.789.
34. Fan X., Pristach C., Liu E.Y., Freudenreich O., Henderson D.C., Goff D.C. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res 2007, 149(1-3):267-271. 10.1016/j.psychres.2006.07.011.
35. Fan X., Liu E.Y., Freudenreich O., Park J.H., Liu D., Wang J., et al. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 2010, 118(1-3):211-217. 10.1016/j.schres.2010.02.1028.
36. Fan X., Borba C.P.C., Copeland P., Hayden D., Freudenreich O., Goff D.C., et al. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand 2013, 127(3):217-226. 10.1111/acps.12009.
37. Fetissov S.O., Déchelotte P. The new link between gut-brain axis and neuropsychiatric disorders. Curr Opin Clin Nutr Metab Care 2011, 14(5):477-482. 10.1097/MCO.0b013e32834936e7.
38. Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16(4):444-453. 10.1016/j.anaerobe.2010.06.008.
39. Francesconi L.P., Ceresér K.M., Mascarenhas R., Stertz L., Gama C.S., Belmonte-de-Abreu P. Increased annexin-V and decreased TNF-α serum levels in chronic-medicated patients with schizophrenia. Neurosci Lett 2011, 502(3):143-146. 10.1016/j.neulet.2011.06.042.
40. Hand T.W., Dos Santos L.M., Bouladoux N., Molloy M.J., Pagán A.J., Pepper M., et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science (New York, NY) 2012, 337(6101):1553-1556. 10.1126/science.1220961.
41. Hemmings G. Schizophrenia. Lancet 2004, 364(9442):1312-1313. 10.1016/S0140-6736(04)17181-X.
42. Hope S., Ueland T., Steen N.E., Dieset I., Lorentzen S., Berg A.O., et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 2013, 145(1-3):36-42. 10.1016/j.schres.2012.12.023.
43. Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol 2013, 25(4):488-795. 10.1097/BOR.0b013e32836208de.
44. Jackson J., Eaton W., Cascella N., Fasano A., Warfel D., Feldman S., et al. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res 2012, 140(1-3):262-263. 10.1016/j.schres.2012.06.011.
45. Jansson B., Kristjánsson E., Nilsson L. Schizophrenic psychosis disappearing after patient is given gluten-free diet. Lakartidningen 1984, 81(6):448-449.
46. Jhamnani K., Shivakumar V., Kalmady S., Rao N.P., Venkatasubramanian G. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci 2013, 25(1):E06-E07. 10.1176/appi.neuropsych.11120376.
47. Ji Y.S., Kim H.N., Park H.J., Lee J.E., Yeo S.Y., Yang J.S., et al. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. Benefic Microbes 2012, 3(1):13-22. 10.3920/BM2011.0046.
48. Jin S.-Z., Wu N., Xu Q., Zhang X., Ju G.-Z., Law M.H., et al. A study of circulating gliadin antibodies in schizophrenia among a Chinese population. Schizophr Bull 2012, 38(3):514-518. 10.1093/schbul/sbq111.
49. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010, 64(6):636-643. 10.1038/ejcn.2010.19.
50. Kalaydjian A.E., Eaton W., Cascella N., Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 2006, 113(2):82-90. 10.1111/j.1600-0447.2005.00687.x.
51. Karlsson H., Blomström Å., Wicks S., Yang S., Yolken R.H., Dalman C. Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 2012, 169(6):625-632. 10.1176/appi.ajp.2012.11081197.
52. Khodaie-Ardakani M.-R., Mirshafiee O., Farokhnia M., Tajdini M., Hosseini S.-M.-R., Modabbernia A., et al. Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study. Psychiatry Res 2014, 215(3):540-546. 10.1016/j.psychres.2013.12.051.
53. Kim J.S., Sampson H.A. Food allergy: a glimpse into the inner workings of gut immunology. Curr Opin Gastroenterol 2012, 28(2):99-103. 10.1097/MOG.0b013e32834e7b60.
54. Kim Y.-K., Myint A.-M., Lee B.-H., Han C.-S., Lee H.-J., Kim D.-J., et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 2004, 28(7):1129-1134. 10.1016/j.pnpbp.2004.05.047.
55. Kraft B.D., Westman E.C. Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutr Metab 2009, 6:10. 10.1186/1743-7075-6-10.
56. Kunz M., Ceresér K.M., Goi P.D., Fries G.R., Teixeira A.L., Fernandes B.S., et al. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 2011, 33(3):268-274.
57. Larsen N., Vogensen F.K., van den Berg F.W.J., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010, 5(2):e9085. 10.1371/journal.pone.0009085.
58. Ledochowski M., Sperner-Unterweger B., Fuchs D. Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Dig Dis Sci 1998, 43(11):2513-2517.
59. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4615-4622. 10.1073/pnas.1000082107.
60. Leonard B.E., Schwarz M., Myint A.M. The metabolic syndrome in schizophrenia: is inflammation a contributing cause?. J Psychopharmacol 2012, 26(5 Suppl):33-41. 10.1177/0269881111431622.
61. Liu F., Guo X., Wu R., Ou J., Zheng Y., Zhang B., et al. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial. Schizophr Res 2014, 153(1-3):169-176. 10.1016/j.schres.2014.01.011.
62. Logan A.C., Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 2005, 64(3):533-538. 10.1016/j.mehy.2004.08.019.
63. McGeachy M.J., McSorley S.J. Microbial-induced Th17: superhero or supervillain?. J Immunol 2012, 189(7):3285-3291. 10.4049/jimmunol.1201834.
64. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011, 105(5):755-764. 10.1017/S0007114510004319.
65. Miller B.J., Mellor A., Buckley P. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses. Brain Behav Immun 2013, 31:82-89. 10.1016/j.bbi.2012.08.016.
66. Mshvildadze M., Neu J., Mai V. Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship?. Nutr Rev 2008, 66(11):658-663. 10.1111/j.1753-4887.2008.00119.x.
67. Muñoz M., Heimesaat M.M., Danker K., Struck D., Lohmann U., Plickert R., et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 2009, 206(13):3047-3059. 10.1084/jem.20090900.
68. Na K.-S., Jung H.-Y., Kim Y.-K. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 2014, 48:277-286. 10.1016/j.pnpbp.2012.10.022.
69. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136(1):65-80. 10.1053/j.gastro.2008.10.080.
70. Niebuhr D.W., Li Y., Cowan D.N., Weber N.S., Fisher J.A., Ford G.M., et al. Association between bovine casein antibody and new onset schizophrenia among US military personnel. Schizophr Res 2011, 128(1-3):51-55. 10.1016/j.schres.2011.02.005.
71. Nieto R., Kukuljan M., Silva H. BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatry 2013, 4:45. 10.3389/fpsyt.2013.00045.
72. Ochoa-Repáraz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009, 183(10):6041-6050. 10.4049/jimmunol.0900747.
73. Ochoa-Repáraz J., Mielcarz D.W., Haque-Begum S., Kasper L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010, 1(2):103-108. 10.4161/gmic.1.2.11515.
74. Okusaga O., Yolken R.H., Langenberg P., Sleemi A., Kelly D.L., Vaswani D., et al. Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry 2013, 14(7):509-515. 10.3109/15622975.2012.747699.
75. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science (New York, NY) 2012, 336(6080):489-493. 10.1126/science.1219328.
76. Parracho H.M.R.T., Bingham M.O., Gibson G.R., McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005, 54(Pt 10):987-991. 10.1099/jmm.0.46101-0.
77. Pedrini M., Massuda R., Fries G.R., de Bittencourt Pasquali M.A., Schnorr C.E., Moreira J.C.F., et al. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 2012, 46(6):819-824. 10.1016/j.jpsychires.2012.03.019.
78. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118(2):511-521. 10.1542/peds.2005-2824.
79. Qurashi I., Collins J., Chaudhry I., Husain N. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia. J Psychopharmacol 2014, 10.1177/0269881114527358.
80. Rao S., Srinivasjois R., Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009, 163(8):755-764. 10.1001/archpediatrics.2009.94.
81. Reichelt K.L., Landmark J. Specific IgA antibody increases in schizophrenia. Biol Psychiatry 1995, 37(6):410-413. 10.1016/0006-3223(94)00176-4.
82. Ribeiro-Santos A., Lucio Teixeira A., Salgado J.V. Evidence for an immune role on cognition in schizophrenia: a systematic review. Curr Neuropharmacol 2014, 12(3):273-280. 10.2174/1570159X1203140511160832.
83. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34(3):J220-J225. 10.1016/j.jaut.2009.11.007.
84. Ryan M.C.M., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160(2):284-289.
85. Schreiner M., Liesenfeld O. Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the literature. Mem Inst Oswaldo Cruz 2009, 104(2):221-233.
86. Severance E.G., Dickerson F.B., Halling M., Krivogorsky B., Haile L., Yang S., et al. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res 2010, 118(1-3):240-247. 10.1016/j.schres.2009.12.030.
87. Severance E.G., Alaedini A., Yang S., Halling M., Gressitt K.L., Stallings C.R., et al. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 2012, 138(1):48-53. 10.1016/j.schres.2012.02.025.
88. Severance E.G., Gressitt K.L., Stallings C.R., Origoni A.E., Khushalani S., Leweke F.M., et al. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 2013, 148(1-3):130-137. 10.1016/j.schres.2013.05.018.
89. Singh M.M., Kay S.R. Wheat gluten as a pathogenic factor in schizophrenia. Science (New York, NY) 1976, 191(4225):401-402.
90. Singh S., Kumar A., Agarwal S., Phadke S.R., Jaiswal Y. Genetic insight of schizophrenia: past and future perspectives. Gene 2014, 535(2):97-100. 10.1016/j.gene.2013.09.110.
91. Smith R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?. Med Hypotheses 1991, 34(3):225-229.
92. Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 1992, 39(3):248-257.
93. Smits L.P., Bouter K.E.C., de Vos W.M., Borody T.J., Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145(5):946-953. 10.1053/j.gastro.2013.08.058.
94. Song X., Fan X., Song X., Zhang J., Zhang W., Li X., et al. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophr Res 2013, 150(1):269-273. 10.1016/j.schres.2013.07.044.
95. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460(7256):744-747. 10.1038/nature08186.
96. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 2006, 27(2):71-80. 10.1016/j.jaut.2006.07.006.
97. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X.-N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004, 558(Pt 1):263-275. 10.1113/jphysiol.2004.063388.
98. Torrey E.F., Bartko J.J., Lun Z.-R., Yolken R.H. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007, 33(3):729-736. 10.1093/schbul/sbl050.
99. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012, 38(3):642-647. 10.1093/schbul/sbs043.
100. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031. 10.1038/nature05414.
101. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457(7228):480-484. 10.1038/nature07540.
102. Vieira S.M., Pagovich O.E., Kriegel M.A. Diet, microbiota and autoimmune diseases. Lupus 2014, 23(6):518-526. 10.1177/0961203313501401.
103. Yu R.-Q., Yuan J.-L., Ma L.-Y., Qin Q.-X., Wu X.-Y. Probiotics improve obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats. Zhongguo Dang Dai Er Ke Za Zhi 2013, 15(12):1123-1127.